How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023.
Saved in:
| Title: | How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023. |
|---|---|
| Authors: | Maticic M; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. prof.maticic@gmail.com.; Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia. prof.maticic@gmail.com., Cernosa J; Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia., Loboda C; Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia., Tamse J; Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia., Rigoni R; Correlation-European Harm Reduction Network, Amsterdam, The Netherlands., Duffell E; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Indave I; European Union Drugs Agency (EUDA), Lisbon, Portugal., Zimmermann R; Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany., Darragh L; Correlation-European Harm Reduction Network, Amsterdam, The Netherlands., Moura J; Correlation-European Harm Reduction Network, Amsterdam, The Netherlands., Leicht A; Fixpunkt E. V., Berlin, Germany., Windelinckx T; Free Clinic, Antwerp, Belgium., Jauffret-Roustide M; Cermes3 (Inserm U988/CNRS 8211/EHESS/Université de Paris), Paris, France., Schiffer K; Correlation-European Harm Reduction Network, Amsterdam, The Netherlands., Tammi T; Finnish Institute for Health and Welfare (THL), Helsinki, Finland. |
| Source: | Harm reduction journal [Harm Reduct J] 2024 Nov 20; Vol. 21 (1), pp. 203. Date of Electronic Publication: 2024 Nov 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101153624 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7517 (Electronic) Linking ISSN: 14777517 NLM ISO Abbreviation: Harm Reduct J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39563360 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Maticic+M%22">Maticic M</searchLink>; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. prof.maticic@gmail.com.; Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia. prof.maticic@gmail.com.<br /><searchLink fieldCode="AU" term="%22Cernosa+J%22">Cernosa J</searchLink>; Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Loboda+C%22">Loboda C</searchLink>; Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Tamse+J%22">Tamse J</searchLink>; Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Rigoni+R%22">Rigoni R</searchLink>; Correlation-European Harm Reduction Network, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Duffell+E%22">Duffell E</searchLink>; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Indave+I%22">Indave I</searchLink>; European Union Drugs Agency (EUDA), Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Zimmermann+R%22">Zimmermann R</searchLink>; Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Darragh+L%22">Darragh L</searchLink>; Correlation-European Harm Reduction Network, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Moura+J%22">Moura J</searchLink>; Correlation-European Harm Reduction Network, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Leicht+A%22">Leicht A</searchLink>; Fixpunkt E. V., Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Windelinckx+T%22">Windelinckx T</searchLink>; Free Clinic, Antwerp, Belgium.<br /><searchLink fieldCode="AU" term="%22Jauffret-Roustide+M%22">Jauffret-Roustide M</searchLink>; Cermes3 (Inserm U988/CNRS 8211/EHESS/Université de Paris), Paris, France.<br /><searchLink fieldCode="AU" term="%22Schiffer+K%22">Schiffer K</searchLink>; Correlation-European Harm Reduction Network, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Tammi+T%22">Tammi T</searchLink>; Finnish Institute for Health and Welfare (THL), Helsinki, Finland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101153624%22">Harm reduction journal</searchLink> [Harm Reduct J] 2024 Nov 20; Vol. 21 (1), pp. 203. <i>Date of Electronic Publication: </i>2024 Nov 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101153624 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-7517 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214777517%22">14777517 </searchLink><i>NLM ISO Abbreviation: </i>Harm Reduct J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39563360 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12954-024-01115-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 203 Titles: – TitleFull: How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Maticic M – PersonEntity: Name: NameFull: Cernosa J – PersonEntity: Name: NameFull: Loboda C – PersonEntity: Name: NameFull: Tamse J – PersonEntity: Name: NameFull: Rigoni R – PersonEntity: Name: NameFull: Duffell E – PersonEntity: Name: NameFull: Indave I – PersonEntity: Name: NameFull: Zimmermann R – PersonEntity: Name: NameFull: Darragh L – PersonEntity: Name: NameFull: Moura J – PersonEntity: Name: NameFull: Leicht A – PersonEntity: Name: NameFull: Windelinckx T – PersonEntity: Name: NameFull: Jauffret-Roustide M – PersonEntity: Name: NameFull: Schiffer K – PersonEntity: Name: NameFull: Tammi T IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 11 Text: 2024 Nov 20 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1477-7517 Numbering: – Type: volume Value: 21 – Type: issue Value: 1 Titles: – TitleFull: Harm reduction journal Type: main |
| ResultId | 1 |